0001209191-19-008514.txt : 20190208
0001209191-19-008514.hdr.sgml : 20190208
20190208162552
ACCESSION NUMBER: 0001209191-19-008514
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190206
FILED AS OF DATE: 20190208
DATE AS OF CHANGE: 20190208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kim Mina
CENTRAL INDEX KEY: 0001668163
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36548
FILM NUMBER: 19580212
MAIL ADDRESS:
STREET 1: C/O SUNRUN INC.
STREET 2: 595 MARKET STREET, 29TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001604464
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 460920988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-278-8930
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-06
0
0001604464
Atara Biotherapeutics, Inc.
ATRA
0001668163
Kim Mina
C/O ATARA BIOTHERAPEUTICS, INC.
611 GATEWAY BOULEVARD, SUITE 900
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Senior VP & General Counsel
Common Stock
2019-02-06
4
A
0
17063
0.00
A
60063
D
Employee Stock Option (Right to Buy)
38.47
2019-02-06
4
A
0
34125
0.00
A
2029-02-05
Common Stock
34125
34125
D
These restricted stock units vest in four equal annual installments on each of the first, second, third and fourth anniversaries of the grant date, subject to the reporting person's continuous service.
Includes 500 shares purchased on November 30, 2018 pursuant to the Issuer's Employee Stock Purchase Plan.
1/48th of the shares subject to the stock option vest and become exercisable each month following February 6, 2019, subject to the reporting person's continuous service..
/s/ David Tucker, Attorney-in-Fact for Mina Kim
2019-02-08